For comparison, in thyroid cancer, ovarian cancer, brain glioma, glioblastoma, and colon adenocarcinoma, where ZnT1 transcript levels were not significantly different, patient survival rates did not differ (Fig. 2c). Here, SLC30A1 is linked to thyroid gland carcinoma.